722 related articles for article (PubMed ID: 25737131)
41. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Z Rheumatol; 2016 Nov; 75(9):924-931. PubMed ID: 26704559
[TBL] [Abstract][Full Text] [Related]
42. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
43. The value of 18F-FDG-PET/CT in the diagnosis of solitary pulmonary nodules: A meta-analysis.
Li ZZ; Huang YL; Song HJ; Wang YJ; Huang Y
Medicine (Baltimore); 2018 Mar; 97(12):e0130. PubMed ID: 29561412
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
Xue M; Liu L; Du G; Fu Z
Urol J; 2020 Apr; 17(6):562-567. PubMed ID: 32309863
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Chu Y; Zheng A; Wang F; Lin W; Yang X; Han L; Chen Y; Bai L
Nucl Med Commun; 2014 Feb; 35(2):144-50. PubMed ID: 24177043
[TBL] [Abstract][Full Text] [Related]
47. Whole-Body
Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
[TBL] [Abstract][Full Text] [Related]
48. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G
Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic test accuracy of
Seol HY; Kim YS; Kim SJ
Clin Radiol; 2021 Nov; 76(11):863.e19-863.e25. PubMed ID: 34261597
[TBL] [Abstract][Full Text] [Related]
50. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic accuracy of
Kim SJ; Lee SW
Br J Radiol; 2018 Jan; 91(1081):20170519. PubMed ID: 29099613
[TBL] [Abstract][Full Text] [Related]
52. (18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis.
Zhao L; He ZY; Zhong XN; Cui ML
Surg Oncol; 2012 Sep; 21(3):230-6. PubMed ID: 22197027
[TBL] [Abstract][Full Text] [Related]
53. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
54. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
[TBL] [Abstract][Full Text] [Related]
55. FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis.
Poulou LS; Ziakas PD; Ziogas DC; Doxani C; Xyla V; Vakrinos G; Voulgarelis M; Thanos L
Biomarkers; 2012 Sep; 17(6):532-8. PubMed ID: 22712479
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
[TBL] [Abstract][Full Text] [Related]
57. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
58. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A
Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767
[TBL] [Abstract][Full Text] [Related]
59. 18FDG PET-CT for detecting gastric cancer recurrence after surgical resection: a meta-analysis.
Zou H; Zhao Y
Surg Oncol; 2013 Sep; 22(3):162-6. PubMed ID: 23747134
[TBL] [Abstract][Full Text] [Related]
60. Can
Du B; Wang S; Cui Y; Liu G; Li X; Li Y
BMJ Open; 2021 Jun; 11(6):e044313. PubMed ID: 34103313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
